^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

TP-0903 is active in models of drug-resistant acute myeloid leukemia

Published date:
12/03/2020
Excerpt:
In vitro and in vivo, TP-0903 was active in multiple models of drug-resistant FLT3 mutant AML, including those involving the F691L gatekeeper mutation and bone marrow microenvironment–mediated factors.
DOI:
10.1172/jci.insight.140169